ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.779,54
-0,58%
S&P 500
5.306,04
0,02%
US Dollar vs BRL
5,1617
-0,22%
Bitcoin
68.480,55
-1,32%
Brent Oil
84,325
1,79%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Scynexis Inc (SCYX)

  7. Scynexis Inc (SCYX) Notícias

SCYX

Scynexis (SCYX)

Scynexis Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SCYX
DataHoraFonteTítuloCódigoCompanhia
08/05/202417:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCYXScynexis Inc
16/02/202419:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SCYXScynexis Inc
13/02/202423:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SCYXScynexis Inc
05/01/202411:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCYXScynexis Inc
28/11/202318:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SCYXScynexis Inc
28/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SCYXScynexis Inc
13/11/202319:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SCYXScynexis Inc
27/09/202321:31GlobeNewswire Inc.SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) due to potential for cross contamination with a non-antibacterial ß-lactam drug substanceNASDAQ:SCYXScynexis Inc
18/07/202317:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SCYXScynexis Inc
23/06/202317:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCYXScynexis Inc
23/06/202317:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCYXScynexis Inc
09/06/202317:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCYXScynexis Inc
01/05/202317:18Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SCYXScynexis Inc
01/05/202317:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SCYXScynexis Inc
01/05/202317:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SCYXScynexis Inc
03/04/202309:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCYXScynexis Inc
31/03/202308:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SCYXScynexis Inc
31/03/202308:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCYXScynexis Inc
30/03/202311:43Dow Jones NewsScynexis Shares Jump 60% After Licensing Deal With GSKNASDAQ:SCYXScynexis Inc
02/12/202215:15TipRanksMaxim Group Remains a Buy on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
02/12/202208:45TipRanksSCYNEXIS (SCYX) Receives a Buy from Ladenburg Thalmann & Co.NASDAQ:SCYXScynexis Inc
10/11/202214:20TipRanksAnalysts’ Top Healthcare Picks: Larimar Therapeutics (LRMR), SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
10/11/202208:45TipRanksLadenburg Thalmann & Co. Reaffirms Their Buy Rating on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
26/10/202217:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SCYXScynexis Inc
26/10/202216:41TipRanksAnalysts Offer Insights on Healthcare Companies: Immunic (IMUX), SCYNEXIS (SCYX) and Karuna Therapeutics (KRTX)NASDAQ:SCYXScynexis Inc
16/08/202214:40TipRanksAnalysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Clene (CLNN)NASDAQ:SCYXScynexis Inc
16/08/202207:05TipRanksH.C. Wainwright Remains a Buy on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
15/08/202222:05TipRanksBrookline Capital Markets Keeps Their Buy Rating on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
15/08/202217:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCYXScynexis Inc
01/08/202214:31TipRanksAnalysts Are Bullish on Top Healthcare Stocks: SCYNEXIS (SCYX), Concert Pharma (CNCE)NASDAQ:SCYXScynexis Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SCYX

Seu Histórico Recente

BIT
P1XXT5
NLBNPIT1XXT5 20240621 0.27
BIT
P1UGW0
NLBNPIT1UGW0 20240620 1700
UNSW
FEIETH
Fei USD
ASE
ALKAR
COIN
HLMUSD
LSE
XX2D
Xchina 50 $
BIT
P1ZZN8
NLBNPIT1ZZN8 20241220 450
NASDAQ
TBCP
Thunder Bridge Capital P...
COIN
STMXKRW
StormX
NYSE
PIM
Putnam Master Intermedia...
BIT
P1ULS8
NLBNPIT1ULS8 20351221 18...
BIT
GS0195
Goldman Sachs
BIT
P21JV6
NLBNPIT21JV6 20240918 5000
EU
IE000Y77LGG9
Lyxor MSCI World ESG Lea...
BIT
P1US30
NLBNPIT1US30 20351221 2....
BIT
P1VAW1
NLBNPIT1VAW1 20351219 72...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados